scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0041-1345(02)03502-9 |
P698 | PubMed publication ID | 12431671 |
P50 | author | Stanislava Stosic-Grujicic | Q39271755 |
Danijela Maksimović-Ivanić | Q39272047 | ||
Miodrag L Lukic | Q63676154 | ||
P2093 | author name string | D Miljkovic | |
M Mostarica Stojkovic | |||
V Trajkovic | |||
P2860 | cites work | Pentoxifylline prevents autoimmune mediated inflammation in low dose streptozotocin induced diabetes | Q28344783 |
Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production. | Q32061593 | ||
Mycophenolate mofetil and its mechanisms of action | Q33957177 | ||
Type I diabetes mellitus. A chronic autoimmune disease | Q34181699 | ||
Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model | Q71197849 | ||
Mycophenolate mofetil can prevent the development of diabetes in BB rats | Q72246392 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2955-2957 | |
P577 | publication date | 2002-11-01 | |
P1433 | published in | Transplantation Proceedings | Q7834825 |
P1476 | title | Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue | |
P478 | volume | 34 |
Q39032639 | From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis |
Q28551762 | In Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine Lymphocytes |
Q57839861 | Mycophenolate mofetil and animal models |
Q45113442 | Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients. |
Q37160327 | The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes |
Search more.